Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Filings indexed 568 across all filing types
Latest filing 2022-03-27 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a public stock issuance by 惠州市锦好医疗科技股份有限公司. It includes specifics on the amount raised, usage of funds, management of idle funds, compliance with regulatory requirements, and audit opinions. The document references regulatory approvals, audit reports, and board meeting resolutions related to the use of raised capital. The content focuses on the actual use and management of the raised funds rather than announcing a new financing event or providing a summary presentation. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is substantive and detailed, not merely an announcement or certification, and is not a full annual or interim report. Therefore, the appropriate classification is CAP with high confidence.
2022-03-27 Chinese
关于治理专项自查及规范活动相关情况的报告
Governance Information Classification · 95% confidence The document is a detailed report from Huizhou Jin Hao Medical Technology Co., Ltd. regarding a special self-inspection and standardization activity related to corporate governance. It includes comprehensive information about the company's governance structure, internal systems, board and management composition, decision-making processes, and compliance with relevant laws and regulations. The content focuses on governance practices, internal controls, and compliance rather than financial performance or audit results. There is no indication that this is an annual report, audit report, earnings release, or any other financial report. The document is not a brief announcement or a certification but a substantive report on governance matters. Therefore, it fits best under the category of Governance Information (CGR).
2022-03-27 Chinese
2021年独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2021" from Huizhou Jin Hao Medical Technology Co., Ltd. It details the independent directors' attendance at board and shareholder meetings, their independent opinions on various board resolutions, participation in training, and efforts to protect investors' rights. The content focuses on governance activities and the independent directors' duties rather than financial results or audit opinions. It is not an annual report, audit report, or earnings release. It is a report on board/management activities specifically related to independent directors' duties and governance. Therefore, the document fits best under Board/Management Information (MANG). The document length is 2357 characters, which is relatively short but contains substantive content about board activities, not just an announcement or certification, so it is not RPA or RNS.
2022-03-27 Chinese
2021年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as an "年度报告摘要" which translates to "Annual Report Summary" for the year 2021. It contains detailed financial data, company business overview, shareholder information, and management assurances about the accuracy of the report. It also references an audit report with an unqualified opinion. The content is comprehensive and covers the company's financial performance and business activities for the full fiscal year 2021. The length of the document (5476 characters) and the detailed financial data indicate this is the actual annual report or a substantial summary of it, not just an announcement or a brief summary. Therefore, it fits the definition of an Annual Report (10-K). FY 2021
2022-03-27 Chinese
第二届监事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Huizhou Jin Hao Medical Technology Co., Ltd. It details the meeting date, attendance, and the approval of various proposals related to the 2021 annual report, financial statements, equity distribution plans, and other corporate governance matters. The document references that the full 2021 annual report and other detailed reports are disclosed separately on the Beijing Stock Exchange website, indicating this document itself is not the full annual report but a meeting resolution announcement. The content focuses on the Supervisory Board's meeting decisions and approvals, which is typical of a Board/Management Information filing. The document length is 3740 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. Therefore, the most appropriate classification is Board/Management Information (MANG).
2022-03-27 Chinese
大信会计师事务所关于惠州市锦好医疗科技股份有限公司控股股东及其他关联方占用资金情况审核报告
Audit Report / Information Classification · 95% confidence The document is titled as an audit report on the use of funds by controlling shareholders and related parties of 惠州市锦好医疗科技股份有限公司. It is issued by a certified public accounting firm and includes audit opinions, responsibilities of management and auditors, and references to specific audit standards. The document is a specialized audit report focusing on a particular aspect of the company's financials rather than a full annual report or interim report. It is not a general regulatory filing or announcement but a standalone audit report. Therefore, it fits the category of Audit Report / Information (AR). The document length is 3437 characters, which is consistent with a detailed audit report but not a full annual report. Hence, the classification is AR with high confidence.
2022-03-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.